Please note: This website has recently moved from www.health.gov to odphp.health.gov. www.health.gov is now the official website of ODPHP’s parent organization, the Office of the Assistant Secretary for Health (OASH). Please update your bookmarks for easy access to all our resources. 

Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: November 2022

The U.S. Preventive Services Task Force (USPSTF) recommends against using combined estrogen and progestin to prevent chronic conditions in postmenopausal people. For people who have gone through menopause and had a hysterectomy, USPSTF recommends against using estrogen alone to prevent chronic conditions. USPSTF has made other recommendations to prevent chronic conditions in adults, which include:

Read more about this resource

Objectives related to this resource (1)

Suggested Citation

1.

U.S. Preventive Services Task Force. (2022). Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication.